New Therapeutic Strategies for Lewy Body Dementias

2017/07/24 by Latha Velayudhan, Dominic Ffytche, Dominic ffytche +2 · 2 citations
Medicine · Neuroscience · Psychology · #Bioinformatics #Biology #Cholinesterase and Neurodegenerative Diseases #Clinical trial #Dementia #Dementia with Lewy bodies #Disease #Donepezil #Galantamine #Ginkgo biloba and Cashew Applications #Internal medicine #Lewy body #Medicine #Monoaminergic #Neuromodulation #Neuroscience #Parkinson's Disease Mechanisms and Treatments #Parkinson's disease #Psychology #Stimulation

paper · doi:10.1007/s11910-017-0778-2

crossref issued 2017/07/24 · crossref published 2017/07/24 · crossref published-online 2017/07/24 · openalex publication_date 2017/07/24 · crossref created 2017/07/24 · crossref published-print 2017/09/01 · crossref deposited 2022/07/31 · openalex created_date 2025/10/10 · crossref indexed 2026/07/18 · openalex updated_date 2026/07/29

Citations

• Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion‐Like Disorder?
• Study of the use of antidepressants for depression in dementia: the HTA-SADD trial – a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine

Cited by

• Pharmacological Management of Dementia with Lewy Bodies
• Dementia with Lewy bodies [wikipedia]